Avelox is a fluoroquinolone (FLQ) known to potentially cause the side effect of peripheral neuropathy. This rare but incredibly serious form of nerve damage is known to cause:
- Chronic nerve pain
- Muscle weakness
- Nerve Spasms
- And more
Cases are already ongoing over FLQs such as Avelox with regards to the side effect of peripheral neuropathy. However, two new studies have highlighted new potential and harmful side effects that may result from using Avelox. Namely, studies have shown that Avelox may increase the risk of aortic aneurysms and aortic dissection.
If you or a loved one has experienced peripheral neuropathy or aortic issues after using an FLQ like Avelox, talk to a Mississippi Avelox lawyer at Maggio Thompson, LLP immediately. A Mississippi Avelox attorney will go over the facts of your case to help you determine whether you are entitled to legal compensation for any injuries or harms that may have been caused by Avelox use.
What Is Avelox?
Avelox is simply the brand name of moxifloxacin, which is a prescription medication that is currently being litigated against in class-action lawsuits centered around the use of FLQs. FLQs are a form of antibiotics designed to typically treat:
- Skin infections
- Urinary tract Infections
- Lower respiratory Infections
- Inflammation from prostate problems, gonorrhea and other inflammation sources
Avelox and Aortic Aneurysms/ Aortic Dissections
A recent study in JAMA Internal Medicine found that current users of FLQs were twice as likely to develop an aortic aneurysm. Double the risk would be bad enough, but an additional study a month later in November of 2015 found that FLQs such as Avelox tripled the aortic aneurysm risk. This second study was conducted by the British Medical Journal.
This news is heartbreaking to hear since aortic aneurysms are capable of sneaking up on people without symptoms being noticed. For this reason, aortic aneurysms are often referred to as “silent killers“. If the symptoms do go unnoticed, the aorta may rip open, leading to internal bleeding capable of causing shock and a rapid death. An aortic aneurysm is a rupture, whereas an aortic dissection is a tear, medically speaking. Both of these harms become an increased risk after FLQ use, according to the latest studies.
Past users of FLQs like Avelox — defined as those who last ingested an FLQ more than 60 days before their event — have been shown to have a statistically increased aneurysm risk of 48%. According to the latest research, these drugs may be weakening the walls of the aorta to such an extent that it is similar to the way FLQs are known to potentially weaken tendons. Numerous studies in the 2000s mentioned that an FLQ could do just that, leading the FDA to order FLQ makers to update their risk information with a Black Box Warning (this is the strongest type of warning the FDA orders).
Despite these correlations, there is not a single word about the potential risk of aortic aneurysm or dissection in the latest FLQ labels. Levaquin (another FLQ similar to Avelox), for example, makes no mention of these risks on its label. As such, our team at Maggio Thompson, LLP is accepting Avelox injury cases. If you or a loved one has been injured by Avelox use, don’t wait to seek representation from an Avelox lawyer in Jackson, MS.
By contacting an Avelox attorney in Jackson, MS, you may be able to receive compensation for the injuries suffered as well as hold drug manufacturers responsible for their products. So don’t wait, contact our team today to receive a legal consultation to discuss the facts of your Avelox injury case.